| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Revenue | $2.20B | +5.6% |
| Cost of Revenue | $1.01B | +4.0% |
| R&D Expense | $265.2M | -0.8% |
| SG&A Expense | $485.1M | +6.1% |
| Operating Income | $701.3M | +11.5% |
| Interest Expense | $65.4M | -1.3% |
| Pre-tax Income | $651.5M | +11.6% |
| Income Tax | $114.4M | -1.2% |
| Net Income | $537.1M |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $423.0M | -0.6% |
| Short-term Investments | $69.6M | +116.1% |
| Accounts Receivable | $228.1M | -4.0% |
| Current Assets | $835.8M | +8.5% |
| Total Assets | $4.06B | +2.3% |
| Current Liabilities | $667.1M | +37.8% |
| Long-term Debt | $1.37B | -15.3% |
| Line Item | 2024-08-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $700.3M | +8.5% |
| Investing Cash Flow | -$144.3M | -51.3% |
| Financing Cash Flow | -$560.9M | +11.3% |
| +14.7% |
| EPS (Basic) | $14.11 | +15.1% |
| EPS (Diluted) | $13.91 | +15.5% |
| Total Liabilities |
| $2.14B |
| -8.6% |
| Stockholders' Equity | $1.91B | +18.1% |